Cardiovascular Disease is a broad category encompassing disorders of the heart and blood vessels. It includes conditions affecting coronary arteries, cerebrovascular circulation, peripheral arteries, cardiac muscle, valves, rhythm and other components of the cardiovascular system. Coronary Artery Disease is therefore one form of Cardiovascular Disease rather than a synonym for the whole category. Cardiovascular diseases can result from atherosclerosis, hypertension, structural abnormalities, inflammation, thrombosis, genetic disorders, infection, degeneration and other mechanisms. They are major causes of illness and death globally, and their prevention and management involve both population-level risk reduction and treatment of established disease.
Atherosclerosis is a major pathological process underlying many forms of Cardiovascular Disease. It involves accumulation of lipids and inflammatory activity within arterial walls, followed by development and remodelling of atherosclerotic plaques. Plaques can progressively narrow arteries or become unstable and rupture, promoting thrombosis. Cardiovascular disease can also arise through mechanisms unrelated to atherosclerotic plaque, such as abnormal electrical conduction, congenital structural defects, cardiomyopathies or valvular degeneration. Consequently, cardiovascular medicine cannot be reduced to cholesterol alone. Different diseases require different diagnostic tests, treatments and preventive strategies.
Major Cardiovascular Disease categories include coronary artery disease, stroke and other cerebrovascular disease, peripheral arterial disease, heart failure, atrial fibrillation and other arrhythmias, valvular heart disease, cardiomyopathies and congenital heart disease. Some conditions affect the heart directly, while others primarily affect blood vessels. The clinical manifestations vary accordingly: coronary disease may cause chest discomfort or myocardial infarction, arrhythmias may cause palpitations or syncope, heart failure can cause breathlessness and fluid retention, and peripheral arterial disease can cause exertional limb pain. A single person can have several cardiovascular conditions simultaneously because they share risk factors and pathological mechanisms.
Cardiovascular risk is influenced by modifiable and non-modifiable factors. Important modifiable factors include smoking, high Blood Pressure, abnormal blood lipid levels, diabetes, physical inactivity, excess body weight and certain dietary patterns. Age, family history, genetic susceptibility and sex-related biological factors also influence risk. Social and environmental determinants can affect exposure to these risks and access to prevention and treatment. Risk assessment commonly combines several variables rather than focusing on one measurement. A person with a moderately abnormal individual factor can have substantial overall risk when several factors coexist, while another person with the same measurement may have a different absolute risk because their overall profile differs.
Diagnosis of Cardiovascular Disease uses history, Physical Examination, Vital Signs and targeted investigations. Electrocardiography assesses cardiac electrical activity, while echocardiography evaluates structure and function. Blood tests can measure biomarkers associated with myocardial injury or other cardiovascular processes, while imaging can assess coronary arteries, cardiac anatomy or blood flow. Exercise testing and ambulatory rhythm monitoring may be useful in selected circumstances. Diagnostic testing should be driven by the clinical question because no single investigation can detect every form of cardiovascular disease. Urgent presentations such as suspected myocardial infarction or stroke require rapid assessment because treatment effectiveness can be highly time-dependent.
Prevention and treatment of Cardiovascular Disease can involve lifestyle measures, medicines, procedures and management of associated conditions. Blood-pressure control, lipid lowering, smoking cessation, diabetes management and appropriate physical activity can reduce cardiovascular risk. Medicines can include statins, antihypertensives, antiplatelet agents, anticoagulants and other therapies selected according to the specific condition. Procedures can include coronary intervention, vascular surgery, valve procedures or electrophysiological treatment where indicated. Preventive treatment must distinguish primary prevention, in people without established cardiovascular disease, from secondary prevention after a cardiovascular event or diagnosis.
Cardiovascular Disease has major consequences because damage to the heart or circulation can impair oxygen delivery to organs and produce acute or chronic disability. Heart attacks and strokes can cause permanent tissue injury, while chronic heart failure and vascular disease can limit exercise capacity and independence. Early recognition of symptoms such as sudden chest discomfort, acute neurological deficit or severe breathlessness can be critical. Rehabilitation, medication adherence, monitoring and long-term risk-factor management are important after cardiovascular events. Cardiovascular care increasingly uses multidisciplinary approaches involving cardiologists, vascular specialists, primary-care clinicians, nurses, pharmacists, physiotherapists, dietetic professionals and rehabilitation services.
Cardiovascular Disease is not synonymous with heart disease because vascular disorders such as peripheral arterial disease and cerebrovascular disease are included within the broader category. Nor does absence of symptoms prove absence of cardiovascular risk; atherosclerosis and hypertension can remain clinically silent for years. Conversely, not every chest pain or palpitation represents cardiovascular disease. The broad nature of the term means that accurate communication should specify the actual condition or suspected mechanism whenever possible. Its significance lies in the interaction between long-term risk-factor exposure, acute vascular events, chronic cardiac dysfunction and opportunities for prevention, with evidence-based risk reduction capable of substantially changing population and individual outcomes.
